Magenta Medical

Self-Expanding Percutaneous Mechanical Circulatory Support

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in October 2012 by Ehud Schwammenthal and Yosi Tuval, Magenta Medical operates with 51–200 employees. The company has raised $224.9M across 5 funding rounds from 12 investors. In July 2024, Magenta Medical secured an E Round of funding, led by.

Business overview

Magenta Medical is a Health Tech & Life Sciences company focused on developing advanced therapies for acute heart failure. The company's core product is the Elevate percutaneous Left Ventricular Assist Device, a catheter-mounted blood pump designed for temporary mechanical circulatory support. This device is intended for hospital-admitted patients undergoing high-risk coronary interventions and those suffering from cardiogenic shock. Magenta Medical serves the healthcare industry, specifically targeting healthcare providers and chronic patients in the cardiology and vascular sectors, with a focus on minimally-invasive medical devices and treatments.

Strategic signal

In July 2024, Magenta Medical secured an E Round of funding, with. This significant capital infusion, which was reported to be $105 million in news coverage, is earmarked to support the company's efforts in securing FDA approval for its innovative heart pump. This indicates strong investor confidence in the company's technology and its potential to advance through regulatory milestones, positioning it for broader market entry and impact in the medical device sector.

Company Intelligence Q&A

What is Magenta Medical's primary product?
Magenta Medical's primary product is the Elevate percutaneous Left Ventricular Assist Device, a catheter-mounted blood pump designed for temporary mechanical circulatory support in patients with acute heart failure.
When was Magenta Medical founded and by whom?
Magenta Medical was founded in October 2012 by Ehud Schwammenthal and Yosi Tuval.
What was the most recent funding event for Magenta Medical?
In July 2024, Magenta Medical secured an E Round of funding. Novo Holdings led this round, with participation from New Enterprise Associates.
Which investors participated in Magenta Medical's May 2023 funding round?
In May 2023, OrbiMed led a funding round for Magenta Medical, with participation from.
What is the current stage of Magenta Medical's product development?
Magenta Medical's product, the Elevate percutaneous Left Ventricular Assist Device, is currently in clinical trials.

External links